A Biotech Bash - Recs and Wrecks Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : A Biotech Bash - Recs and Wrecks

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: LLCF who wrote (137)	9/13/1997 7:49:00 AM
From: r. peter Dale	of 171

A number of smaller biotech firms have been doing well recently. One I've followed for years and which was in the headlines last week is Compumed (CMPD). The company makes bone and joint scanning systems for the visualization of osteoporosis and arthritis. Earlier this week the company announced a prototype of its latest model would be on display a national conference this week/weekend (http://biz.yahoo.com/prnews/97/09/09/cmpd_cpmd_1.html). The company's stock, which had been severely impacted by an unfavorable licensing agreement with Merck for an earlier model (which does not apply to the latest system), was up ~100% for the week on huge volume. I've been unable to find any follow-up stories nor learn of third party opinions of the new device. However, if this new system simply performs the osteoporosis side of its claims, and with the company sure to insist on more palatable licensing/distribution arrangements, demographics would argue this small one may have a bright future. Best wishes, Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next